Peptide-based cancer therapy: Opportunity and challenge

被引：265
|
作者：
Wu, Dongdong [1 ]
Gao, Yanfeng [2 ]
Qi, Yuanming [2 ]
Chen, Lixiang [2 ]
Ma, Yuanfang [1 ]
Li, Yanzhang [1 ]
机构：
[1] Henan Univ, Coll Med, Kaifeng 475004, Henan, Peoples R China
[2] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China
来源：
CANCER LETTERS | 2014年 / 351卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Cancer therapy; Peptide; Anticancer mechanism; Modification strategy; ENDOTHELIAL GROWTH-FACTOR; PHAGE DISPLAY LIBRARY; HUMAN FIBROSARCOMA CELLS; EXHIBITS ANTITUMOR-ACTIVITY; TARGETED DRUG-DELIVERY; INHIBITS TUMOR-GROWTH; ANTIMICROBIAL PEPTIDE; BREAST-CANCER; ANTICANCER ACTIVITY; IN-VITRO;
D O I：
10.1016/j.canlet.2014.05.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Cancer is one of the leading causes of death worldwide. Conventional cancer therapies mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities. Peptides are a novel class of anticancer agents that could specifically target cancer cells with lower toxicity to normal tissues, which will offer new opportunities for cancer prevention and treatment. Anticancer peptides face several therapeutic challenges. In this review, we present the sources and mechanisms of anticancer peptides and further discuss modification strategies to improve the anticancer effects of bioactive peptides. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：13 / 22
页数：10
相关论文
共 50 条
  • [41] Composite peptide-based vaccines for cancer immunotherapy
    Yang, Jie
    Zhang, Qing
    Li, Ke
    Yin, Hong
    Zheng, Jun-Nian
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (01) : 17 - 23
  • [42] Peptide-based imaging agents for cancer detection
    Sun, Xiaolian
    Li, Yesen
    Liu, Ting
    Li, Zijing
    Zhang, Xianzhong
    Chen, Xiaoyuan
    ADVANCED DRUG DELIVERY REVIEWS, 2017, 110 : 38 - 51
  • [43] Recent developments in peptide-based cancer therapeutics
    Sehgal, A
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (02) : 245 - 250
  • [44] Peptide-based vaccines for cancer: realizing their potential
    Kanodia, Shreya
    Kast, W. Martin
    EXPERT REVIEW OF VACCINES, 2008, 7 (10) : 1533 - 1545
  • [45] Peptide-based targeting of immunosuppressive cells in cancer
    Trac, Noah T.
    Chung, Eun Ji
    BIOACTIVE MATERIALS, 2020, 5 (01) : 92 - 101
  • [46] Peptide-Based Prodrug Approaches for Cancer Nanomedicine
    Ul Khaliq, Nisar
    Amin, Laraib
    Ul Khaliq, Saad
    Amin, Anam
    Omer, Samreen
    Ul Khaliq, Ihtisham
    Kim, Yejin
    Kim, Joohyeon
    Kim, Taeho
    Seo, Dongseong
    Sung, Daekyung
    Kim, Hyungjun
    ACS APPLIED BIO MATERIALS, 2024, : 8163 - 8176
  • [47] Peptide-based delivery of therapeutics in cancer treatment
    Samec, Timothy
    Boulos, Jessica
    Gilmore, Serena
    Hazelton, Anthony
    Alexander-Bryant, Angela
    MATERIALS TODAY BIO, 2022, 14
  • [48] Immune responses to peptide-based cancer vaccines
    Jager, E
    Knuth, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1302 - 1302
  • [49] Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
    Yang, Seong-Bin
    Banik, Nipa
    Han, Bomin
    Lee, Dong-Nyeong
    Park, Jooho
    PHARMACEUTICS, 2022, 14 (07)
  • [50] Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent
    Stefflova, Klara
    Li, Hui
    Chen, Juan
    Zheng, Gang
    BIOCONJUGATE CHEMISTRY, 2007, 18 (02) : 379 - 388
12345